ArticleCancer reports (Hoboken, N.J.)2026

ANXA1/FPR Signaling Contribute to Paclitaxel Resistance in Ovarian Cancer Through PI3K/AKT-Associated PGC1α Regulation.

Zhou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.